Page 185 - E-book การประชุมวิชาการครั้งที่ 36

36. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, et al. Revised
Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and

microsatellite instability. J Natl Cancer Inst. 2004;96:261-8.

37. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Feasibility of
screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783-8.

38. Puangsricharoen P, Manchana T, Ariyasriwatana C, Triratanachat S.

Immunohistochemistry staining for the mismatch repair proteins in endometrial cancer patients.
Thai J Obstet Gynaecol. 2020;28:79-85.

39. Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and

the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl
Cancer Inst. 2013;105:1607-16.

40. Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S, et al. Peutz-Jeghers

syndrome: a systematic review and recommendations for management. Gut. 2010;59:975-86.
41. Masciari S, Dillon DA, Rath M, Robson M, Weitzel JN, Balmana J, et al. Breast cancer

phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.

Breast Cancer Res Treat. 2012;133:1125-30.
42. Kamihara J, Rana HQ, Garber JE. Germline TP53 mutations and the changing landscape

of Li-Fraumeni syndrome. Hum Mutat. 2014;35:654-62.

43. Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, et al.
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers. J Clin Oncol. 2015;33:2345-52.

44. Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, et al. Beyond Li

Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol.
2009;27:1250-6.

45. Chompret A, Abel A, Stoppa-Lyonnet D, Brugiéres L, Pagés S, Feunteun J, et al.

Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet.
2001;38:43-7.

46. van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, et

al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline
CDH1 mutation carriers. J Med Genet. 2015;52:361-74.

Genetic related gynecologic disorders and genetic testing 169